This product is an intermediate product of sugar metabolism in the body. It produces pharmacological effects by regulating the activity of several enzymes in sugar metabolism. Exogenous 1,6-diphosphate fructose can increase the concentration of adenosine triphosphate and creatine phosphate in cells, promote the influx of potassium ions, increase the content of diphosphoglycerate in red blood cells, inhibit the release of oxygen free radicals and histamine, and has many other pharmacological effects. It can reduce the damage caused by ischemia and hypoxia, especially for ischemic heart disease.

This product has a reasonable ratio of essential amino acids and non-essential amino acids, high bioavailability, and can be effectively used in the synthesis of human protein

This product has a reasonable ratio of essential amino acids and non-essential amino acids, high bioavailability, and can be effectively used in the synthesis of human protein

This product has a reasonable ratio of essential amino acids and non-essential amino acids, high bioavailability, and can be effectively used in the synthesis of human protein

This product has a reasonable ratio of essential amino acids and non-essential amino acids, high bioavailability, and can be effectively used in the synthesis of human protein

This product has a reasonable ratio of essential amino acids and non-essential amino acids, high bioavailability, and can be effectively used in the synthesis of human protein

It complies with the Vuj-N formula ratio and can be effectively used in the synthesis of human protein with high bioavailability.

It complies with the Vuj-N formula ratio and can be effectively used in the synthesis of human protein with high bioavailability.

It complies with the Vuj-N formula ratio and can be effectively used in the synthesis of human protein with high bioavailability.

It complies with the Vuj-N formula ratio and can be effectively used in the synthesis of human protein with high bioavailability.

It complies with the Vuj-N formula ratio and can be effectively used in the synthesis of human protein with high bioavailability.

It can enter cells without insulin and inhibit the formation of ketone bodies, save protein, improve amino acid utilization, and promote liver glycogen accumulation. It has no adverse effect on sugar metabolism and has not caused metabolic complications.

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc. It also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

It can make the endometrium enter a complete secretory phase, thereby preventing the risk of endometrial hyperplasia and cancer caused by estrogen. Dydrogesterone can be used for various diseases with insufficient endogenous progesterone. Dydrogesterone has no estrogen, androgen and adrenal cortex hormone effects. Dydrogesterone does not produce heat and has no effect on lipid metabolism.